TM9SF3

Transmembrane 9 superfamily member 3 · Q9HD45 · TM9SF3 on Sugi Atlas →

0 patent compounds predicted against TM9SF3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TM9SF3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma PHASE2UNKNOWN
Pembrolizumab (MK-3475) in MM Patients With Residual Disease PHASE2COMPLETED
ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy PHASE2COMPLETED
68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis EARLY_PHASE1UNKNOWN
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis EARLY_PHASE1RECRUITING
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors nanUNKNOWN
Evaluation of Risk of hEpatocellular Carcinoma nanRECRUITING
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors nanNOT_YET_RECRUITING
The Development of Human Immunologic Assays Specific to Folate Receptor Antigen nanUNKNOWN
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects nanUNKNOWN
Lifestyle Intervention in Fatty Liver (NAFLD) nanUNKNOWN
Clinical Research on 68Ga-FAPI PET/CMR in Cardiovascular Diseases nanRECRUITING
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1-positive Tumors of Digestive System nanUNKNOWN
Study of Constitutional Platelet Disease nanUNKNOWN
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism nanUNKNOWN
Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin nanCOMPLETED
Differential Expression of CD200 in B-chronic Lymphoproliferative Disorders by Multicolour Flow Cytometry nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Metabolic Flexibility, Gut Microbiota, Healthy Diet and Exercise in NAFLD on Genetics Base nanCOMPLETED
Genetic Study of Age-Related Macular Degeneration nanCOMPLETED
Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS nanCOMPLETED
Immunophenotypic Evaluation of CD305 and CD85d in B-Cell Lymphoid Neoplasms nanNOT_YET_RECRUITING
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Molecular & Clinical Evaluation of Low HDL Syndromes nanCOMPLETED
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a TM9SF3 binder may also engage these)

ProteinNameSimilarity
Q9ET30 1.000 Q9ET30 →
A5D7E2 1.000 A5D7E2 →
Q8BH24 1.000 Q8BH24 →
F4KIB2 1.000 F4KIB2 →
TM9SF2 Transmembrane 9 superfamily member 2 1.000 landscape →
Q9FYQ8 1.000 Q9FYQ8 →
P58021 1.000 P58021 →
Q940G0 1.000 Q940G0 →
Q9LIC2 1.000 Q9LIC2 →
Q8RWW1 1.000 Q8RWW1 →
Q66HG5 1.000 Q66HG5 →
Q5RDY2 0.999 Q5RDY2 →
Q9C720 0.999 Q9C720 →
F4JRE0 0.999 F4JRE0 →
TM9SF4 Transmembrane 9 superfamily member 4 0.999 landscape →
Q9C5N2 0.998 Q9C5N2 →
Q4KLL4 0.998 Q4KLL4 →
Q5R8Y6 0.997 Q5R8Y6 →
O15321 0.997 O15321 →
Q5R8F1 0.997 Q5R8F1 →
Q55FP0 0.996 Q55FP0 →
A4IFE9 0.995 A4IFE9 →
Q04562 0.994 Q04562 →
F4HW17 0.992 F4HW17 →
Q54ZW0 0.992 Q54ZW0 →
Q9Y819 0.991 Q9Y819 →
Q66HF2 0.991 Q66HF2 →
A9UY97 0.990 A9UY97 →
Q9DBU0 0.990 Q9DBU0 →
P32802 0.989 P32802 →